Skills to Enhance Positive Affect in Suicidal Adolescents (STEP)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02130583 |
Recruitment Status :
Completed
First Posted : May 5, 2014
Results First Posted : January 24, 2019
Last Update Posted : March 5, 2019
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Suicidal Ideation Suicide, Attempted | Behavioral: Positive Affect Skills Training Behavioral: Treatment as Usual | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 52 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | Skills to Enhance Positive Affect in Suicidal Adolescents |
Study Start Date : | August 2013 |
Actual Primary Completion Date : | September 2, 2016 |
Actual Study Completion Date : | September 2, 2016 |
Arm | Intervention/treatment |
---|---|
Experimental: Positive Affect Skills Training
Individual sessions (3-4) delivered on the inpatient unit, focused on psycho-education regarding positive affect and mood monitoring and teaching of skills to attend to positive affect such as mindfulness, gratitude, and savoring. In-person sessions are followed by weekly phone calls and daily text messages for one month, with option to extend.
|
Behavioral: Positive Affect Skills Training
Individual sessions (3-4) delivered on the inpatient unit, focused on psycho-education regarding positive affect and mood monitoring and teaching of skills to attend to positive affect such as mindfulness, gratitude, and savoring. In-person sessions are followed by weekly phone calls and daily text messages for one month, with option to extend. |
Active Comparator: Treatment as Usual
Participants will follow the intervention plan laid out in their discharge summary, but do not receive any individual sessions regarding positive affect. Upon discharge, they will receive generic text messages regarding healthy habits for one month, with option to extend.
|
Behavioral: Treatment as Usual
Participants will follow the intervention plan laid out in their discharge summary, but do not receive any individual sessions regarding positive affect. Upon discharge, they will receive generic text messages regarding healthy habits for one month, with option to extend. |
- Dot Probe Task [ Time Frame: Baseline, 1 month Post Treatment, 4 month Follow-Up ]Dot probe tasks are administered to assess for attentional biases. The task is a computer task in which participants are presented with stimuli (e.g., words) of different valences (positive/negative/neutral) at the same time (e.g., smiling face and a neutral face), followed by a probe (*) on one side. Participants are asked to hit a key that corresponds to the correct side in which the probe appeared. The reaction time of their response is indicative of their attention to the valenced image/word. Trials are counterbalanced so that valences appear equally on each side. Faster reaction time (less milliseconds) to positive images/words indicates an attentional bias for positive stimuli. The scores reported here represent bias scores. Positive scores indicate a bias to positive stimuli, negative scores indicate a bias towards neutral stimuli.
- Modified Differential Emotions Scale (Positive Emotions Sub-scale) [ Time Frame: Base, 1 month Post-Treatment, 4 month Follow-Up ]The Modified Differential Emotions Scale is a self-report measure comprised of ratings for positive and negative affect. For example, participants are asked to rate the extent to which they feel "Content, serene, peaceful right now" on a likert scale ranging from 1 (not at all) to 5 (extremely). The scores reported are averages for the positive emotions, and thus can be interpreted as ranging from 1 (not at all) to 5 (extremely). We expected an increase in positive affect ratings following the intervention.
- Suicide Events [ Time Frame: 1 month, 6 month ]Number of participants who have attempted suicide or have had emergency intervention to intercede a suicide attempt.
- Suicide Ideation Questionnaire (SIQ) [ Time Frame: Baseline, 1 month Post-Treatment, 4 month Follow-Up ]The Suicidal Ideation Questionnaire is a 30 item self-report measure that was administered to the adolescent to ascertain the frequency of thoughts of death and suicide. Respondents are asked how often they have had these thoughts (e.g., "I thought about killing myself") in the past month ranging from "almost every day" = 1 to "I never had this thought" =7. Scores are then reversed and transformed such that higher scores indicate higher suicidal ideation, with a range of 180 (highest suicidal ideation) to 0 (no suicidal ideation).
- Beck Depression Inventory [ Time Frame: Baseline, 1 month Post-Treatment, 4 month Follow-Up ]The Beck Depression Inventory is a 21 item self-report form of depression but can be and has been administered to the parent to respond about their child. This questionnaire consists of 21 groups of statements. For example, for "Sadness", respondents are asked to select between 0 ("My child does not feel sad."), 1 ("My child feels sad much of the time"), 2 ("My child is sad all the time"), and 3 ("My child is so sad or unhappy that he/she can't stand it."). Higher scores indicate higher depression with a maximum score of 63 and a minimum score of 0.
- Columbia Impairment Scale Parent Version [ Time Frame: Base, 1 month Post-Treatment, 4 month Follow-Up ]The Columbia Impairment Scale (parent version) is a 13-item scale in which parents are asked to respond about their child's impairment in a variety of domains on a scale of 0 (no problem at all) to 4 (very bad problem). Scores are summed such that higher scored indicate higher functional impairment, with a maximum score of 52 and a minimum score of 0.
- Hopelessness Scale for Children [ Time Frame: Baseline, 1 month Post-Treatment, 4 month Follow-Up ]The Hopelessness Scale for Children is a 17 item self-report scale with statements (e.g., I want to grow up because I think things will be better) that are rated as either True or False. Some statements are reverse coded. Higher scores indicate higher hopelessness, with a maximum score of 17 and a minimum score of 0.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 12 Years to 18 Years (Child, Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- current hospital admission due to concern of suicide risk
- ability of patient to speak, read, and understand English sufficiently well to complete the procedures of the study
- living at home
Exclusion Criteria:
- active psychotic disorder
- cognitive deficits that preclude full understanding of study materials
- adolescents who have become wards of the state and do not intend to return to the home of their biological or adoptive parents

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02130583
United States, Rhode Island | |
Butler Hospital | |
Providence, Rhode Island, United States, 02906 |
Principal Investigator: | Shirley Yen, Ph.D. | Brown University |
Responsible Party: | Shirley Yen, Associate Professor (Research), Brown University |
ClinicalTrials.gov Identifier: | NCT02130583 |
Other Study ID Numbers: |
R34MH101272 ( U.S. NIH Grant/Contract ) |
First Posted: | May 5, 2014 Key Record Dates |
Results First Posted: | January 24, 2019 |
Last Update Posted: | March 5, 2019 |
Last Verified: | February 2019 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Yes |
Plan Description: | Data available upon completion of study by request. |
Supporting Materials: |
Study Protocol Informed Consent Form (ICF) Clinical Study Report (CSR) |
Time Frame: | 9/1/17 |
Access Criteria: | Please contact PI at 401-444-1915 |
Suicide Suicidal Ideation Suicide, Attempted Self-Injurious Behavior Behavioral Symptoms |